Integrating single-cell regulatory atlas and multi-omics data for differential treatment response and multimodal predictive modeling in CDK 4/6 inhibitor-treated breast cancer
IntroductionCDK4/6 inhibitors are cornerstone therapies for advanced HR+/HER2- breast cancer, yet treatment response heterogeneity remains a major clinical challenge. This study integrates single-cell regulatory landscapes with multi-omics data to decode resistance mechanisms and develop predictive...
Saved in:
Main Authors: | Li Yan, Sijie Chen, Ran Ran, Shidi Zhao, Jing Huang, Jin Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1585574/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring Autophagy-Related Gene Expression in Hepatocellular Carcinoma via TCGA, GEPIA2, and HPA Databases: Implications for Prognosis
by: Gu X, et al.
Published: (2025-07-01) -
The construction and evaluation of a prognostic risk score model for HCC based on MPT-related lncRNAs
by: Zerun Lin, et al.
Published: (2025-07-01) -
New insights into the dule roles CDK12 in human cancers: Mechanisms and interventions for cancer therapy
by: Wei Dai, et al.
Published: (2025-07-01) -
Development of CDK4/6 Inhibitors in Gastrointestinal Cancers: Biomarkers to Move Forward
by: Ioannis A. Voutsadakis
Published: (2025-06-01) -
Construction and validation of a post-translational modification-related signature to predict the effect of immune therapies in gastric cancer
by: Shi-Zhou Deng, et al.
Published: (2025-09-01)